The JCO Podcast hosted by Dr. Shannon Westin features discussions of new and noteworthy results publ
A meta-analysis of 7 randomized trials comparing EGFR kinase inhibitors to chemotherapy for advanced
This podcast discusses a novel immunotherapy approach using an allogeneic whole tumor cell vaccine t
In summary, healthcare providers caring for breast cancer patients hopefully recognize the need for
Review and comments on BFM experience of ALL hematopoietic transplantation.
This podcasts provides perspective on a recent report evaluating disease volume and surgical complex
In this podcast, Dr. Claire Snyder discusses how patient-reported outcomes provide a critical perspe
An analysis of the PROFILE studies and opportunities for treatment of ALK-rearranged non-small cell
The development and practical utility of a model developed in the Mayo benign breast disease cohort
This JCO Podcast provides observations and commentary on the JCO article, "Large retroperitoneal lym
This is an oral commentary on patients with endometrial or rectal cancer, and their risk of developi
In a randomized RTOG study of chemotherapy concurrent with accelerated vs standard fractionated radi
This podcast reviews the available data from clinical trials using cyclooxygenase-2 inhibition with
This four-arm randomized controlled trial of cognitive behavioral therapy for insomnia in cancer pat
This podcast is a review of the submitted article by Dr. Wentzensen and colleagues regarding multipl
A secondary analysis of a multicenter randomized trial suggests that the R-ACVBP regimen may improve
Modifying therapy based upon positive DTCs in breast cancer.
NCIC SC.20 demonstrates that a second course of radiation for painful osseous metastases significant
Long-term follow up from the landmark, NCI-sponsored adjuvant trastuzumab trials confirms the clinic
This podcast provides a commentary on the association of braf mutation and thyroid cancer showing an
In this podcast, the results of the S0008 adjuvant intergroup trial are discussed and placed in the